Everyday Health on MSN
5 DIY Tricks to Calm Scalp Psoriasis Irritation
For symptoms of scalp psoriasis, home treatments like olive oil, oatmeal, and apple cider vinegar may provide relief and make ...
Psoriasis can feel like an uninvited guest that shows up on your skin and refuses to leave. Those red, scaly patches—often ...
Psoriasis isn't just a skin condition. It's an autoimmune disease that can shape your mental and emotional world too.
About 7.5 million Americans have psoriasis. But, despite psoriasis being a fairly common skin condition, it's often misunderstood. In case you're not familiar with it, psoriasis is a condition that ...
Psoriasis treatment has come a long way. New medications like biologics have helped more people achieve clearer skin. But everyone with psoriasis is different. What works for one person won't always ...
More than 50% of patients with psoriasis are eligible for systemic treatment, and nearly 90% would switch to an effective oral therapy with a favorable safety profile.
Psoriasis is a chronic skin disease where red, scaly, itchy patches break out all over your body. It’s an autoimmune disease in which your immune system goes haywire and triggers inflammation of your ...
Following certification, STRATA has initiated its commercial rollout in partnership with MINO Labs, a leading Mexican pharmaceutical and medical device commercialization firm. The first TheraClearX® ...
Psoriasis can significantly affect a person's self-esteem and emotional well-being. Luciana Pereira da Conceição, a 62-year-old professor, shares her struggle with the condition, stating that her ...
Early childhood stress, especially before age 1, significantly increases psoriasis risk, with an odds ratio of 4.19. The study involved over 16,000 children, using data from the All Babies in ...
Every year on 29 October, World Psoriasis Day raises awareness of the 125 million people worldwide living with PsA ...
MedPage Today on MSN
More Trial Details Reported for Novel Psoriasis Pill
Subgroup analyses from one of the agent's pivotal trials showed that 29.5% of adolescents receiving icotrokinra achieved PASI ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results